Clinically, researchers have attempted to evaluate the efficacy of oral coated FMT plus supplementary fiber supplementation in a representative population with severe obesity and metabolic syndrome in North America and found that oral FMT can alter the microbial ecology of the recipient, thereby improving insulin sensitivity. The gene discussed is INS; the disease is obesity disorder.